Squarepoint’s Safeguard Scientifics SFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-12,897
Closed -$82K – 3755
2020
Q4
$82K Buy
+12,897
New +$80.5K ﹤0.01% 2749
2020
Q2
– Sell
-16,213
Closed -$90K – 2592
2020
Q1
$90K Sell
16,213
-31,864
-66% -$285K ﹤0.01% 1665
2019
Q4
$528K Sell
48,077
-183
-0.4% -$2.09K ﹤0.01% 1746
2019
Q3
$547K Buy
48,260
+34,394
+248% +$410K ﹤0.01% 1572
2019
Q2
$167K Buy
+13,866
New +$162K ﹤0.01% 2141
2018
Q4
– Sell
-14,470
Closed -$135K – 2312
2018
Q3
$135K Buy
14,470
+3,249
+29% +$35.3K ﹤0.01% 1845
2018
Q2
$144K Buy
+11,221
New +$145K ﹤0.01% 1593
2018
Q1
– Sell
-15,607
Closed -$175K – 2257
2017
Q4
$175K Buy
+15,607
New +$200K ﹤0.01% 1834

Other funds holding SFE

Squarepoint's SFE Position: Q1 2021 in Review

Squarepoint sold out of Safeguard Scientifics (SFE) in Q1 2021, closing a stake of 12,897 shares — an estimated $82K sold.

Squarepoint first reported a position in SFE in Q4 2017 and held it in 8 quarters. The position peaked at $547K in Q3 2019. 84 funds tracked by Wall St. Rank hold SFE as of Q1 2021.

  • Squarepoint reported no remaining Safeguard Scientifics position as of Q1 2021 after selling out during the quarter.
  • Squarepoint sold 12,897 Safeguard Scientifics shares in Q1 2021, an estimated $82K.
  • Squarepoint first reported a position in Safeguard Scientifics in Q4 2017 and held it in 8 quarters.
  • Squarepoint's Safeguard Scientifics position peaked at $547K in Q3 2019.
  • 84 funds tracked by Wall St. Rank held Safeguard Scientifics as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.